| ABIRATERONE ACETATE |
|
|
USFDA and WHO-GMP |
|
|
✓ |
| ACYCLOVIR EP/ IP/ USP/ PH.INT |
|
|
WHO GMP |
|
|
|
| ADAPALENE |
|
|
WHO GMP |
|
|
|
| ADENOSINE |
|
|
GMP |
|
|
✓ |
| ALPHA LIPOIC ACID |
|
|
WHO-GMP |
|
|
✓ |
| AMILORIDE HCL |
|
|
WHO-GMP |
|
|
✓ |
| AMOROLFINE HYDROCHLORIDE IH |
|
|
WHO-GMP |
|
|
✓ |
| ANIDULAFUNGIN IH |
|
Applied |
WHO GMP |
✓ |
|
✓ |
| AMLODIPINE BESYLATE USP/PH.EUR. |
|
|
WHO GMP |
|
|
✓ |
| APIXABAN IH |
|
✓ |
WHO-GMP |
|
|
✓ |
| APREPITANT |
|
|
WHO-GMP |
|
|
✓ |
| ARTEMETHER IP/ PH.INT |
|
|
who-gmp |
|
|
|
| ARTESUNATE IP/ PH.INT |
|
|
who-gmp |
|
|
|
| ARIPIPRAZOLE IP/PH. EUR/ JP |
|
|
WHO GMP |
|
|
|
| ATORVASTATIN CALCIUM AMORPHOUS/ CRYSTALINE -USP/EP/ICH |
|
|
WHO GMP |
|
|
✓ |
| ATRACURIUM BESYLATE USP & PH.EUR. |
|
✓ |
USFDA Plant |
|
✓ |
|
| AZELAIC ACID – IH |
|
|
|
|
|
|
| AZITHROMYCIN -IP/BP/USP |
|
|
WHO- GMP |
|
|
✓ |
| ACYCLOVIR |
|
✓ |
WHO GMP |
|
|
✓ |
| BENFOTIAMINE IH |
|
|
WHO GMP |
|
|
✓ |
| BETAMETHASOONE SOD. PHOSPHATE |
|
|
GMP |
|
|
✓ |
| BETHANECHOL CHLORIDE |
|
|
GMP |
|
|
|
| BETADEX SULFOBUTYL ETHER SODIUM USP – NF |
|
|
USFDA Plant |
|
✓ |
|
| BETAMETHASONE ACETATE USP STERILE |
|
|
USFDA Plant |
|
✓ |
|
| BISOPROLOL FUMARATE USP/ EP |
|
|
WHO GMP |
|
|
|
| BILASTINE |
|
|
WHO GMP |
✓ |
|
✓ |
| BIPERIDEN HCL PH. EUR/USP |
|
|
WHO GMP |
|
|
|
| BRINZOLAMIDE- USP / IP |
|
|
WHO GMP |
|
|
|
| BORTEZOMIB IH |
|
|
WHO GMP |
|
|
✓ |
| BOSENTAN MONOHYDRATE IP/IH |
|
|
WHO GMP |
|
|
Under development |
| BUPROPION HCL USP |
|
|
WHO GMP |
|
✓ |
✓ |
| CANDESARTAN CILEXETIL USP/EP |
|
|
WHO GMP |
|
|
✓ |
| CARVEDILOL – IP, USP, PH.EUR, BP |
|
|
WHO GMP |
|
|
✓ |
| CAPECITABINE USP/EP/IP |
|
|
WHO GMP |
|
|
✓ |
| CARGLUMIC ACID |
|
|
WHO GMP, USFDA TRIGGERED |
|
|
✓ |
| CA-SALT OF ALPHA KETO ISOLEUCINE |
|
|
WHO GMP |
✓ |
|
✓ |
| CA-SALT OF ALPHA KETO LEUCINE |
|
|
WHO GMP |
✓ |
|
✓ |
| CA-SALT OF ALPHA KETO METHIONINE |
|
|
WHO GMP |
✓ |
|
✓ |
| CA-SALT OF ALPHA KETO PHENYL ALANINE |
|
|
WHO GMP |
✓ |
|
✓ |
| CA-SALT OF ALPHA KETO VALINE |
|
|
WHO GMP |
✓ |
|
✓ |
| CARISOPRODOL USP/PH.EUR/IP |
|
|
WHO GMP & USFDA |
|
✓ |
✓ |
| CASPOFUNGIN ACETATE IH |
|
✓ |
WHO-GMP & USFDA |
|
✓ |
✓ |
| CELECOXIB USP/PH.EUR |
|
|
WHO GMP |
|
|
✓ |
| CISATRACURIUM BESYLATE USP & PH.EUR. |
|
|
WHO GMP & USFDA |
|
✓ |
✓ |
| CLOTRIMAZOLE |
|
✓ |
WHO GMP |
✓ |
|
✓ |
| CHLORTHALIDONE |
|
|
WHO GMP |
|
|
✓ |
| CHLORPROMAZINE HCL |
|
|
WHO GMP |
|
|
✓ |
| CILNIDIPINE IH |
|
|
GMP |
|
|
✓ |
| CITICOLINE SODIUM IH/ IP |
|
|
WHO GMP |
|
|
✓ |
| CLOPIDOGREL BISULFATE F-II USP/PH.EUR/ |
|
|
WHO GMP |
✓ |
|
✓ |
| CLOBETASOL PROPIONATE |
|
|
WHO GMP |
|
|
✓ |
| COLISTIMETHATE SODIUM |
|
|
WHO GMP |
|
|
✓ |
| DABIGARTAN ETEXILATE MESYLATE |
|
|
WHO-GMP |
|
|
|
| DANAZOL |
|
|
GMP |
|
|
✓ |
| DALTEPARIN SODIUM PH.EUR. |
|
|
USFDA Plant |
|
✓ |
|
| DAPAGLIFLOZIN |
|
|
WHO-GMP |
|
|
✓ |
| DARUNAVIR ETHANOLATE |
|
|
WHO GMP |
|
|
✓ |
| DEFERASIROX |
|
|
WHO-GMP |
|
|
✓ |
| DEFERIPRONE |
|
|
WHO-GMP |
|
|
✓ |
| DEFLAZACORT IH |
|
|
WHO GMP |
|
|
✓ |
| DEGARELIX ACETATE |
|
|
WHO GMP |
|
|
✓ |
| DESLORATADINE- ICH/EP/USP |
|
|
WHO-GMP |
|
|
✓ |
| “DESVENLAFAXINE HYDROCHLORIDE” |
|
|
GMP |
|
|
✓ |
| DEXLANSOPRAZOLE IP/IH |
|
|
WHO-GMP |
|
|
✓ |
| “DEXTAMETHASONE SOD. PHOSPHATE” |
|
|
GMP |
|
|
✓ |
| “DEXTROMETHORPHAN HYDROBROMIDE” |
|
|
GMP |
|
|
✓ |
| DIATRIZOIC ACID |
|
|
WHO – GMP |
|
|
|
| DICLOFENAC SODIUM |
|
|
WHO – GMP |
|
|
|
| DOLUTEGRAVIR SODIUM IH |
|
|
GMP |
|
|
|
| DOMEPERIDONE MALEATE- IP/EP/BP/JP |
|
|
WHO GMP |
✓ |
|
✓ |
| DORZOLAMIDE HCL |
|
|
WHO – GMP |
|
|
✓ |
| DONEPEZIL HYDROCHLORIDE MONOHYDRATE- IP/USP/JP |
|
|
GMP |
|
|
✓ |
| EMPAGLIFLOZIN IH |
|
|
USFDA/ WHO |
|
|
✓ |
| EPINASTINE HCL |
|
|
GMP |
|
|
✓ |
| ERYTHROMYCIN LACTOBIONATE IH |
|
|
WHO-GMP |
|
✓ |
|
| ERLOTINIB HYDROCHLORIDE IH |
|
|
WHO-GMP |
|
|
Under development |
| ESOMEPRAZOLE MAGNESIUM DIHYDRATE |
|
|
USFDA and WHO GMP |
|
|
✓ |
| ESOMEPRAZOLE MAGNESIUM TRIHYDRATE |
|
✓ |
USFDA and WHO GMP |
|
✓ |
|
| ESOMEPRAZOLE SODIUM |
|
|
WHO GMP / USFDA |
|
|
✓ |
| ETOMIDATE USP & PH.EUR |
|
|
WHO GMP |
|
✓ |
|
| ENALAPRIL MALEATE |
|
|
WHO GMP |
|
|
✓ |
| ENTACAPONE |
|
|
WHO – GMP |
|
|
✓ |
| ENTICAVIR – IH, IP, USP, PH.EUR |
|
|
WHO- GMP |
|
|
✓ |
| ERYTHROMYCIN STEARATE |
|
|
WHO GMP |
|
|
✓ |
| ETORICOXIB – IH,IP |
|
|
WHO – GMP |
|
|
✓ |
| ETODOLAC |
|
|
GMP |
|
|
✓ |
| EVEROLIMUS EP/IH |
|
|
WHO GMP |
|
|
✓ |
| EZETIMIBE- IN-HOUSE , USP, IP |
|
|
WHO-GMP |
|
|
✓ |
| FAVIPIRAVIR |
|
|
WHO- GMP |
|
✓ |
✓ |
| EPERISONE JP |
|
|
WHO |
|
|
✓ |
| FEXOFENADINE HYDROCHLORIDE- IP/USP/BP/EP/JP |
|
|
WHO GMP |
|
|
✓ |
| FEBUXOSTAT |
|
|
GMP |
|
|
✓ |
| FENOFIBRATE |
|
|
WHO GMP |
|
|
✓ |
| FERRIC CARBOXYMALTOSE |
|
|
WHO- GMP |
Applied |
|
✓ |
| FUROSEMIDE |
|
✓ |
WHO- GMP |
|
|
✓ |
| FLUTICASONE PROPIONATE- I.P/B.P/E.P/U.S.P |
|
|
GMP |
|
|
✓ |
| FLUCONAZOLE- USP, PH.EUR, IP, BP |
|
|
WHO GMP |
|
|
✓ |
| FLUBIPROFEN |
|
|
WHO- GMP |
|
|
✓ |
| FOLIC ACID- IP/BP/USP |
|
Applied |
WHO GMP / USFDA |
✓ |
|
✓ |
| FOSFOMYCIN SODIUM USP/EP/BP |
|
|
WHO GMP |
|
|
✓ |
| FOSFOMYCIN TROMETAMOL USP/EP/BP |
|
|
WHO GMP |
|
|
✓ |
| FOSFOMYCIN CALCIUM |
|
|
WHO GMP |
|
|
✓ |
| GEMCITABINE HCL |
|
|
GMP |
|
|
✓ |
| GLICLAZIDE |
|
|
WHO- GMP |
|
✓ |
✓ |
| GLYCINE |
|
|
GMP |
|
|
✓ |
| HALOPERIDOL BASE |
|
|
GMP |
|
|
✓ |
| HYDRALAZINE HCL |
|
|
WHO- GMP |
|
|
✓ |
| HYDROXY CHLOROQUINE SULFATE |
|
✓ |
WHO- GMP |
|
|
✓ |
| ILAPRAZOLE |
|
|
WHO |
|
|
✓ |
| IRBESARTAN |
|
|
WHO- GMP |
|
|
✓ |
| IRON (III)HYDROXIDE POLYMALTOSE COMPLEX |
|
|
WHO- GMP |
|
|
|
| IRON DEXTRAN |
|
|
WHO- GMP |
|
|
|
| IRON DEXTRAN COMPLEX IH |
|
|
USFDA |
|
✓ |
|
| IRON SORBITOL |
|
|
WHO- GMP |
|
|
|
| IRON SUCROSE COMPLEX IH |
|
|
WHO GMP |
✓ |
|
✓ |
| IRON SUCROSE CONCENTRATE LIQUID |
|
|
WHO GMP |
✓ |
|
✓ |
| ITRACONAZOLE IP/PH. EUR/USP/BP |
|
|
WHO |
|
|
|
| KETOCONAZOLE- IP/USP/EP |
|
|
WHO – GMP |
|
|
✓ |
| KETOPROFEN |
|
|
WHO- GMP |
|
|
✓ |
| LABETALOL |
|
|
|
|
|
|
| LACTOSE MONOHYDRATE IMPALPABLE AND PALPABLE – IP/BP/ USP |
|
|
WHO- GMP |
|
|
✓ |
| LACOSAMIDE EP |
|
|
WHO-GMP AND USFDA |
|
✓ |
✓ |
| LANSOPRAZOLE |
|
|
WHO – GMP |
|
|
✓ |
| LAPATINIB DITOSYLATE IP/IH |
|
|
WHO – GMP |
|
|
Under development |
| LEVETIRACETAM |
|
✓ |
US FDA / WHO-GMP |
|
✓ |
✓ |
| LEVOSALBUTAMOL SULPHATE- IH/ IP |
|
|
|
|
|
|
| LEVOTHYROXINE SODIUM USP |
|
|
WHO-GMP |
|
✓ |
|
| LINAGLIPTIN |
|
|
USFDA/WHO-GMP |
|
✓ |
✓ |
| LINEZOLID |
|
|
WHO GMP |
|
|
|
| LISINOPRIL USP/PH.EUR |
|
|
WHO GMP |
|
|
|
| LORATADINE- USP/BP/EP |
|
|
WHO – GMP |
|
|
✓ |
| LOSARTAN POTTASIUM- IP/USP/BP/EP/JP |
|
|
WHO – GMP |
|
|
✓ |
| LORNOXICAM- IH |
|
|
GMP |
|
|
✓ |
| LOXOPROFEN SODIUM |
|
|
WHO GMP |
|
|
✓ |
| LULICONAZOLE IH |
|
|
GMP |
|
|
✓ |
| L-GLUTATHIONE |
|
|
WHO – GMP |
|
|
✓ |
| MEFENAMIC ACID USP/EP/BP/IP |
|
|
WHO – GMP |
|
|
✓ |
| METFROMIN IP/BP/USP |
|
|
WHO – GMP |
|
|
✓ |
| METHYLPREDNISOLONE BASE |
|
|
WHO – GMP |
|
|
✓ |
| METHYLCOBLAMIN |
|
|
WHO – GMP |
|
|
✓ |
| METHYLENE BLUE |
|
|
GMP |
|
|
|
| MIRABEGRON |
|
✓ |
WHO/USFDA |
|
|
✓ |
| MICAFUNGIN SODIUM IH |
|
|
WHO – GMP |
|
|
✓ |
| MIDOSTAURIN IH |
|
|
WHO – GMP |
|
|
Under development |
| MITOMYCIN C |
|
|
WHO – GMP |
|
|
Under development |
| MONTELUKAST SODIUM |
|
|
WHO – GMP |
|
|
✓ |
| MOXIFLOXACIN HCL USP/PH.EUR/IP |
|
|
WHO- GMP |
|
|
✓ |
| MYCOPHENOLATE MOFETIL USP/EP/IP |
|
|
WHO – GMP |
|
|
Under development |
| MUPIROCIN |
|
|
WHO – GMP |
|
|
Under development |
| NALOXONE HYDROCHORIDE- I.P/B.P/E.P/U.S.P |
|
|
WHO – GMP |
|
|
✓ |
| NADIFLOXACIN |
|
|
GMP |
|
|
✓ |
| NEBIVOLOL HYDROCHLORIDE |
|
|
WHO- GMP |
|
|
Under Development |
| NEOSTIGMINE METHYLSULFATE USP |
|
|
WHO- GMP |
|
|
✓ |
| NICARDIPINE HYDROCHLORIDE USP |
|
|
GMP |
|
|
✓ |
| NIMESULIDE |
|
✓ |
WHO- GMP |
|
|
✓ |
| NITROFURANTOIN |
|
✓ |
WHO- GMP |
|
|
✓ |
| NITROFURANTOIN MACRO CRYSTAL |
|
✓ |
WHO- GMP |
|
|
✓ |
| OBETICHOLIC ACID |
|
|
GMP |
|
|
✓ |
| OLANZAPINE |
|
|
WHO – GMP |
|
|
✓ |
| OLMESARTAN MEDOXOMIL USP/IP/BP |
|
✓ |
WHO- GMP |
|
✓ |
✓ |
| OMEPRAZOLE |
|
✓ |
WHO- GMP |
|
|
✓ |
| OMEPRAZOLE MAGNESIUM |
|
|
WHO- GMP |
|
|
✓ |
| OMEPRAZOLE SODIUM |
✓ |
|
WHO- GMP |
|
|
✓ |
| OSELTAMIVIR PHOSPHATE |
Filed |
|
WHO- GMP |
|
|
✓ |
| PALIPERIDONE PALMITATE |
|
|
WHO- GMP |
|
|
✓ |
| PALIPERIDONE PALMITATE STERILE IH |
|
|
WHO- GMP |
|
|
✓ |
| PANTOPRAZOLE SODIUM SESQUIHYDRATE |
|
✓ |
WHO – GMP |
|
|
✓ |
| PEMETREXED DISODIUM IP |
|
|
WHO – GMP |
|
|
Under development |
| PIDOTIMOD |
|
|
WHO – GMP |
|
|
✓ |
| PIRFENIDONE IP/USP/PH.EUR |
|
|
WHO- GMP |
|
|
✓ |
| PIMECROLIMUS IH |
|
|
WHO – GMP |
|
|
✓ |
| PLERIXAFOR IH |
|
|
USFDA |
|
✓ |
|
| PARACETAMOL- IP/BP/USP |
|
|
WHO- GMP |
|
|
✓ |
| PERINDOPRIL ERBUMINE |
|
|
WHO GMP |
|
|
✓ |
| POSACONAZOLE |
|
|
WHO GMP |
|
|
✓ |
| PREGABLIN IP/PH. EUR/USP |
|
✓ |
WHO- GMP |
|
|
|
| POLYMYXIN B SULPHATE |
|
|
WHO GMP |
|
|
✓ |
| PRAZOSIN |
|
|
Who gmp |
|
|
✓ |
| “PREDNISOLONE SOD. PHOSPHATE” |
|
|
GMP |
|
|
✓ |
| PYRANTEL PAMOATE |
|
|
GMP |
|
|
✓ |
| QUININE SULPHATE- I.P/B.P/U.SP |
|
|
GMP |
|
|
✓ |
| QUETIAPINE FUMARATE IP/USP/PH.EUR |
|
|
WHO- GMP |
|
|
✓ |
| RAMIPRIL- I.P/E.P/B.P/U.S.P. |
|
|
WHO GMP |
|
|
✓ |
| RETAPAMULIN IH |
|
|
WHO GMP |
|
|
Under development |
| RIFAXIMIN |
|
|
WHO GMP |
|
|
✓ |
| ROSUVASTATIN CALCIUM- I.H.S/I.P/E.P/USP |
|
|
WHO GMP |
|
|
✓ |
| RUPATADINE FUMARATE- IP/EP |
|
|
GMP |
|
|
✓ |
| RABEPRAZOLE SODIUM IP/PH. EUR/JP/BP |
|
|
WHO- GMP |
|
|
✓ |
| RAMELTEON |
|
|
WHO- GMP |
|
|
✓ |
| RIBOFLAVIN (VITAMIN B2) |
|
|
WHO- GMP |
|
|
✓ |
| RISPERIDONE |
|
✓ |
WHO- GMP |
|
|
✓ |
| RIVAROXABAN |
FILLED |
|
WHO/USFDA |
|
|
✓ |
| ROCURONIUM BROMIDE USP & PH.EUR |
|
|
USFDA |
|
✓ |
|
| ROPINIROLE HCL |
|
|
WHO GMP |
|
|
✓ |
| SAXAGLIPTIN |
|
|
WHO/USFDA |
|
|
✓ |
| SERTRALINE HCL IP/USP/PH.EUR |
|
|
USFDA |
✓ |
✓ |
✓ |
| SEVELAMER CARBONATE |
|
|
WHO GMP |
|
|
✓ |
| SITAGLIPTIN PHOSPHATE MONO HYDRATE IP/USP/PH.EUR |
|
|
WHO/USFDA |
|
|
✓ |
| SERTACONAZOLE NITRATE- PH.EUR, BP |
|
|
WHO- GMP |
|
|
✓ |
| SALBUTAMOL SULPHATE- I.P/B.P/E.P/U.S.P |
|
|
WHO- GMP |
|
|
✓ |
| SODIUM STEARYL FUMARATE- U.S.P/NF |
|
|
WHO GMP |
|
|
✓ |
| SODIUM VALPROATE |
|
|
GMP |
|
|
✓ |
| SORAFENIB IH |
|
|
WHO GMP |
|
|
✓ |
| SILODOSIN |
|
|
WHO- GMP |
|
|
✓ |
| SOLIFENACIN SUCCINATE |
|
|
WHO- GMP |
|
|
✓ |
| SUGAMMADEX SODIUM IH |
|
|
WHO- GMP |
|
|
✓ |
| SULFADOXINE |
|
✓ |
WHO- GMP |
|
|
✓ |
| SUCRALFATE |
|
|
WHO- GMP |
YES |
|
✓ |
| TACROLIMUS- IHS |
|
|
WHO GMP |
|
|
✓ |
| TADALAFIL- USP/ IP |
|
|
WHO GMP |
|
|
✓ |
| TAMSULOSIN HYDROCHLORIDE |
|
|
WHO- GMP |
|
|
✓ |
| TAPENTADOL IP/IHS |
|
|
GMP |
|
|
✓ |
| TENOFOVIR |
|
|
WHO- GMP |
|
|
✓ |
| TELMISARTAN IP/ USP |
|
|
WHO GMP |
|
|
✓ |
| TETRACAINE BASE |
|
✓ |
USFDA |
|
✓ |
✓ |
| TETRACAINE HCL EP/USP |
|
✓ |
USFDA |
|
✓ |
✓ |
| THIAMINE MONONITRATE (VITAMIN B1) |
|
|
WHO- GMP |
|
|
✓ |
| TICAGRELOR EP/BP/USP/IH |
|
|
GMP |
|
|
✓ |
| TIGECYCLINE USP |
|
|
WHO- GMP |
|
|
✓ |
| TRIENTINE HCL |
|
|
WHO- GMP |
|
|
✓ |
| TIROFIBAN HYDROCHLORIDE IH |
|
|
WHO- GMP |
|
|
✓ |
| TOLFENAMIC ACID EP/BP |
|
|
WHO- GMP |
|
|
✓ |
| TOLTERODINE TARTRATE |
|
|
WHO- GMP |
|
|
✓ |
| TOPIRAMATE |
|
|
WHO- GMP |
|
|
✓ |
| TORSEMIDE |
|
|
WHO- GMP |
|
|
✓ |
| VALGANCICLOVIR HYDROCHLORIDE |
|
|
GMP |
|
|
✓ |
| VENLAFAXINE |
|
|
WHO- GMP |
|
|
✓ |
| VORICONAZOLE |
|
|
GMP |
|
|
✓ |
| VILDAGLIPTIN |
|
|
WHO- GMP |
|
✓ |
✓ |
| WARFARIN SODIUM AMORPHOUS |
|
✓ |
WHO- GMP |
|
✓ |
✓ |
| WARFARIN SODIUM CLATHRATE |
|
|
WHO- GMP |
|
✓ |
✓ |
| ZINC SULFATE HEPTAHYDRATE USP |
|
|
GMP |
|
|
✓ |
| ZIPRASIDONE MESILATE TRIHYDRATE PH.EUR |
|
|
WHO-GMP |
|
|
✓ |